About ISoP - A message from the President of ISoP

Sten Olsson - President of ISoP

Sten Olsson – President of ISoP
2016 – Current

ISoP is becoming a mature organization, having gone through generations of development since the early 1990s, and is right now entering into a new phase.

Last July, an extraordinary general assembly adopted new statutes for the Society and on the basis of the process defined in these statutes a new leadership was elected by ISoP members. Having been elected President of the Society through this democratic process provides me with a positive mandate to lead the organization for the next three years, in close collaboration with the Advisory Board, from which four of us form the Executive Committee. We feel empowered by this mandate but also spurred on by the expectations on us to deliver services that will meet the needs of the expanding pharmacovigilance profession. Let me assure you that we are committed to expanding ISoP services to meet those needs, provided that you, our members, are clear in letting us know what those needs are. We intend to create improved opportunities for an active dialogue between members and the Executive Committee. It is through such interactions that we can remain well informed of global developments in pharmacovigilance, allowing us to ensure that ISoP remains relevant, with the power to keep present- and attract new members.

ISoP has a strong foundation in scientific research relating to many different aspects of medicine-related harm and patient safety. Our annual meeting provides an important forum for scientific discussion, exchange of experiences and socializing. It is essential for the identity of the Society that the annual meeting remains attractive to all pharmacovigilance professionals. An online subscription to Drug Safety, the official journal of the Society, is provided as a very valuable part of the ISoP membership fee. This very significant source of scientific information and knowledge is probably insufficiently appreciated by ISoP members and needs to be further promoted.

Not all pharmacovigilance professionals necessarily identify themselves as researchers however. They might be involved in very important aspects of pharmacovigilance e.g. data management, writing Risk Management or Risk Minimization Plans, or work as Qualified Persons for Pharmacovigilance in pharmaceutical companies. ISoP must develop its services to ensure that all pharmacovigilance professionals around the world will identify the Society as the natural forum for access to professional support, development of best practices and information exchange. ISoP is open to anyone subscribing to the vision and values of the Society. Through its national and regional Chapters ISoP is adapting its activities to cater for specific needs for services and support identified in different geographic areas. Engaging in the Chapter activities allows more ISoP members to contribute to the dynamic development of the Society.

As I’m writing this welcome address we have just successfully finished the 16th Annual ISoP Meeting, held in the fabulous city of Agra, India. In spite of the competition for attention from Taj Mahal and other World Heritage sites in the area, we had a great meeting both professionally and socially and ISoP thanks and congratulates the local organizing committee, chaired by Professor K.C Singhal, and the scientific committee, led by Dr Kenneth Hartigan-Go, for putting together an exciting and rewarding programme for all ISoP members who were able to make it to Agra.

Welcome to ISoP!

Sten Olsson
President of the International Society of Pharmacovigilance